Trial intelligence / Profile preview

Landiolol in septic shock patients with persistent tachycardia in ICU

2017-002138-22Phase 4Completed

Sponsor
AOP Health
Start
Aug 2017
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of landiolol in septic shock, sponsored by AOP Health. Started Aug 2017; status: completed.

02

Drugs

landiolol
03

Conditions

septic shock

Beyond the preview

Go deeper on 2017-002138-22.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2017-002138-22.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call